Optimization and in vivo toxicity evaluation of G4.5 PAMAM dendrimer-risperidone complexes
Risperidone is an approved antipsychotic drug belonging to the chemical class of benzisoxazole. This drug has low solubility in aqueous medium and poor bioavailability due to extensive first-pass metabolism and high protein binding (.90%). Since new strategies to improve efficient treatments are nee...
Guardado en:
| Autores principales: | Prieto, María Jimena, Rio Zabala, Nahuel Eduardo del, Marotta, Cristian Hernán, Carreño Gutierrez, Hector, Arevalo Arevalo, Rosario, Chiaramoni, Nadia Silvia, Alonso, Silvia del Valle |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/102625 https://ri.conicet.gov.ar/11336/31250 |
| Aporte de: |
Ejemplares similares
-
G4.5 Pamam Dendrimer-Risperidone: Biodistribution and Behavioral Changes in In Vivo Model
por: Prieto, María Jimena, et al.
Publicado: (2013) -
Effect of Risperidone and Fluoxetine on the Movement and Neurochemical Changes of Zebrafish
por: Prieto, María Jimena, et al.
Publicado: (2012) -
PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases : A biophysical and nanotoxicological characterization
por: Igartúa, Daniela Edith, et al.
Publicado: (2018) -
Combined Therapy for Alzheimer’s Disease : Tacrine and PAMAM Dendrimers Co-Administration Reduces the Side Effects of the Drug without Modifying its Activity
por: Igartúa, Daniela Edith, et al.
Publicado: (2020) -
Selective cytotoxicity of PAMAM G5 core-PAMAM G2.5 shell tecto-dendrimers on melanoma cells
por: Schilrreff, Priscila, et al.
Publicado: (2012)